Stock-Based Compensation - Non plan Stock Options (Details) - Forge Nano, Inc. - USD ($) $ / shares in Units, $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Aug. 08, 2022 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Stock-Based Compensation | |||
| Granted | 82,512 | 102,974 | 150,161 |
| Vesting period | 42 days | 4 years | |
| Exercise price | $ 96.95 | $ 165.43 | $ 31.56 |
| Pre-money valuation amount | $ 300,000 | ||
| Fully diluted shares | 3,094,378 | ||
| Exercised | $ 121.19 | $ 6.86 | $ 15.81 |
| X | ||||||||||
- Definition Number of fully diluted shares used as an input in determining the exercise price at the grant date for a sharebased payment arrangement. No definition available.
|
| X | ||||||||||
- Definition Amount of the premoney valuation used to determine the grant date exercise price for a sharebased payment arrangement. No definition available.
|
| X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|